Diplomacy

  • Most Popular
  • Most Shared

REUTERS SHOWCASE

India Credit Rating

India Credit Rating

No case for S&P ratings downgrade: Mayaram.  Full Article 

Tax Tangle

Tax Tangle

Infosys to challenge new tax demand of $105.3 million.  Full Article 

Gold Outlook

Gold Outlook

Gold futures to fall past one-month low.  Full Article 

It's a Deal

It's a Deal

Morgan Stanley to sell India wealth management unit to StanChart.  Full Article 

Money Triangle

Money Triangle

Despite curbs, China's vast hot money triangle flourishes.  Full Article 

Buy, Sell or Hold?

Buy, Sell or Hold?

Confused while buying stocks? Get buy, sell or hold recommendations from VantageTrade.  Full Coverage 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage 

Cinven buys Mercury Pharma from HgCapital for $732 mln

Related Topics

Stocks

   

LONDON | Fri Aug 17, 2012 12:47pm IST

LONDON Aug 17 (Reuters) - Investor HgCapital has sold British pharmaceutical company Mercury Pharma to private equity firm Cinven for 465 million pounds ($732 million).

"The realisation of Mercury Pharma marks the continued development of HgCapital's investment focus in the healthcare sector," said HgCapital's head of healthcare, Philipp Schwalber, in a statement on Friday.

"We continue to seek out businesses that enjoy niches of secular growth despite the challenges facing much of the healthcare space," he said.

HgCapital bought the 25-year-old pharmaceutical firm, which sells niche prescription off-patent products in the UK, Ireland and the Netherlands, in 2009.

It said its listed investment trust HgCapital Trust expects to receive 35.4 million pounds in cash on the sale completion and further potential proceeds of 1 million pounds over the next 30 months.

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.